Market watch: Sales from licensed and acquired products to increase by 2013

Abstract

AVos Life sciences has analysed the revenue contribution of organically developed, licensed or co-developed, acquired and joint venture products to the major rx drug portfolios (MrDPs: the collection of branded drugs that are each predicted to generate at least us$500 million in annual sales) of the top 14 pharma ceutical companies (see supplementary… (More)
DOI: 10.1038/nrd2912

Topics

1 Figure or Table

Cite this paper

@article{Goodman2009MarketWS, title={Market watch: Sales from licensed and acquired products to increase by 2013}, author={Michael Wayne Goodman}, journal={Nature Reviews Drug Discovery}, year={2009}, volume={8}, pages={443-443} }